Heidelberg Pharma AG (LON: 0QW5)
London
· Delayed Price · Currency is GBP · Price in EUR
2.570
+0.020 (0.78%)
At close: Jan 15, 2025
Heidelberg Pharma AG Revenue
Heidelberg Pharma AG had revenue of 1.19M EUR in the quarter ending August 31, 2024, a decrease of -46.82%. This brings the company's revenue in the last twelve months to 8.47M, down -10.39% year-over-year. In the fiscal year ending November 30, 2023, Heidelberg Pharma AG had annual revenue of 9.86M, down -46.75%.
Revenue (ttm)
8.47M EUR
Revenue Growth
-10.39%
P/S Ratio
n/a
Revenue / Employee
89.18K EUR
Employees
95
Market Cap
97.75M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Nov 30, 2023 | 9.86M | -8.66M | -46.75% |
Nov 30, 2022 | 18.51M | 16.48M | 810.30% |
Nov 30, 2021 | 2.03M | -6.63M | -76.53% |
Nov 30, 2020 | 8.67M | 1.17M | 15.63% |
Nov 30, 2019 | 7.50M | 3.69M | 97.10% |
Nov 30, 2018 | Pro | Pro | Pro |
Nov 30, 2017 | Pro | Pro | Pro |
Nov 30, 2016 | Pro | Pro | Pro |
Nov 30, 2015 | Pro | Pro | Pro |
Nov 30, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 38.20B |
Shell | 221.41B |
HSBC Holdings | 43.25B |
Unilever | 51.12B |
Rio Tinto Group | 42.87B |
RELX PLC | 9.30B |
BP p.l.c. | 144.69B |
British American Tobacco p.l.c. | 26.18B |